Fairvalue-Calculator Fairvalue-Calculator
EN DE

Vycor Medical, Inc (VYCO) Fair Value & Analysis

Healthcare · US · Market cap $2.2M

Price$0.0660
Fair Value$0.0290
Upside-56.0%
Quality95/100
Evidence: Low Range $0.0290 – $0.0356

Fair value as of: Jun 26, 2026

✦ Find undervalued quality stocks — 34,000+ analysed Find stocks →

Analysis

Vycor Medical, Inc (VYCO) currently trades at $0.0660, while our model-based Fair Value estimate is $0.0290 — implying the stock looks roughly 56.0% overvalued today. We read business quality at 95/100 (high quality), in the Healthcare sector. Bear case: priced above our estimate, the market already discounts strong expectations. Bull case: above-average quality can justify a premium — the entry price still matters most (evidence: low).

About the company

Vycor Medical, Inc. designs, develops, and markets neurological medical devices and therapies in the United States and Europe. The company operates through two segments: Vycor Medical and NovaVision. Its Vycor Medical segment provides devices for neurosurgery comprising ViewSite Brain Access System, a retraction and access system for brain and spine surgeries. The NovaVision segment offers non-invasive computer-based rehabilitation therapies targeted at people who have impaired vision as a result of stroke or other brain injury. It has a license agreement with a German-based partner. It primarily serves hospitals and medical professionals. The company was incorporated in 2005 and is headquartered in Boca Raton, Florida. Vycor Medical, Inc. operates as a subsidiary of Fountainhead Capital Management Ltd.

Open the full interactive analysis →

Similar stocks

Abbott Laboratories, (ABT) -95% Stryker Corporation (S1YK34) -45% Medtronic plc (MDT) -27% Boston Scientific Corporation (B1SX34) -11% Edwards Lifesciences Corporation (EW) -52% Siemens Healthineers AG (SEMHF) +11%

Frequently asked questions

Is Vycor Medical, Inc (VYCO) undervalued?
As of Jun 26, 2026, our model estimates a fair value of $0.0290 versus a price of $0.0660 — about −56% (overvalued). Model-based estimate, not financial advice.
What is the fair value of VYCO?
Our 21-model fair value for Vycor Medical, Inc is $0.0290 (as of Jun 26, 2026), built from audited fundamentals. The current price is $0.0660.
What is the quality score of VYCO?
Vycor Medical, Inc has a Quality Score of 95/100, measuring profitability, growth and balance-sheet strength from non-valuation factors.

How we calculate Fair Value

Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.

Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.